Opens 1600L/1000L reactor stream at Oxford, UK and increases API capacity at Verona, Italy Greenwich, CT, April 2, 2015 - Dr. Jonathan Goldman, CEO, Aptuit LLC, announced that Aptuit has increased its ...

Significant increase in capacity to scale of millions of capsules/tablets, new capabilities and addition of commercial drug product license Greenwich, CT, - Aptuit LLC announced it has augmented ...

GREENWICH, Conn.--(BUSINESS WIRE)--Aptuit, Inc. announced today that it has signed an agreement to acquire the assets and operations of EaglePicher Pharmaceutical Services (EPPS) – the first step ...

Aptuit, Inc. today announced that it has completed the acquisition of the Chemical and Pharmaceutical Development (CPD) business of Evotec, which integrates an active pharmaceutical ingredient (API) ...

Pharmaceutical services firm Aptuit has agreed to acquire EaglePicher's pharmaceutical services unit, consisting of active pharmaceutical ingredient plants in Lenexa, Kans., and Harrisonville, Mo., ...

Dr. Jonathan Goldman, CEO, Aptuit LLC, announced that Aptuit has increased its global capacity for Active Pharmaceutical Ingredient (API) Manufacture due to increased demand for API, and for its ...

Greenwich, CT, July 15, 2014 -- Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit's sales and ...

GREENWICH, Conn., Jan. 9, 2015 /PRNewswire/ — Dr. Jonathan Goldman, CEO, Aptuit LLC, announced that Aptuit has divested its aseptic clinical manufacturing site in Glasgow, UK to Albany Molecular ...

A range of services from process development to clinical manufacturing will be proffered. Aptuit secured its first integrated drug delivery contract from Danube Pharmaceuticals. Aptuit will provide ...

Jonathan Goldman, CEO of Aptuit LLC, announced today that Henning Steinhagen, PhD, has been named as President, Research and Development Operations. Henning will continue in his existing role of ...

Continuing its buildup of a pharmaceutical development services business, Aptuit has agreed to acquire Evotec's chemical and pharmaceutical development operations for $64 million. The business, which ...

GREENWICH, Conn., July 15, 2014 /PRNewswire/ -- Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of ...